Xcellerex, Inc. and Gallus Biopharmaceuticals, LLC Announce Biomanufacturing Collaboration

Xcellerex, Inc. and Gallus BioPharmaceuticals, LLC today announced that they have entered into a collaboration that quickly provides Gallus with expanded cGMP biomanufacturing capacity by leveraging the key advantages of the turnkey Xcellerex FlexFactory® GMP manufacturing platform suite. The strategic collaboration will provide Gallus with world-class, scalable, flexible and cost-efficient manufacturing and laboratory technology to expand its contract manufacturing business. In addition this partnership will provide Xcellerex’s customers unprecedented access to a commercial, FDA approved, biomanufacturing facility.

Back to news